LivaNova (LIVN) FCF Payout Ratio (2016 - 2017)

LivaNova (LIVN) posted FCF Payout Ratio of 0.21 for Q1 2017, up 2108.62% sequentially from 0.01 in Q4 2016, and down 89.3% YoY from 1.95 in Q1 2016.

LivaNova (LIVN) FCF Payout Ratio (2016 - 2017) Analysis & Trends

LivaNova has reported FCF Payout Ratio for 2 years, with the latest figure at 0.21 in Q1 2017.

Quarterly FCF Payout Ratio fell 89.3% year-over-year to 0.21 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was 0.13 (changed N/A YoY) and the FY2016 annual result came in at 0.12, changed N/A from the prior year.
FCF Payout Ratio climbed to 0.21 in Q1 2017 per LIVN's latest filing, from 0.01 in the prior quarter.
Over five years, FCF Payout Ratio peaked at 1.95 in Q1 2016 and troughed at 0.01 in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Abbott Laboratories	200.11 Bn	194.51 Bn	7.27 Bn	0.55
2	Stryker	129.85 Bn	126.37 Bn	4.50 Bn	0.32
3	Medtronic	119.93 Bn	110.71 Bn	6.41 Bn	0.44
4	Boston Scientific	74.18 Bn	73.64 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.54 Bn	48.29 Bn	1.35 Bn	-
6	Dexcom	34.76 Bn	32.81 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.25 Bn	32.14 Bn	2.18 Bn	0.24
8	Koninklijke Philips	26.45 Bn	23.13 Bn	4.55 Bn	-0.73
9	Steris	23.29 Bn	22.80 Bn	684.20 Mn	0.22
10	LivaNova	4.33 Bn	3.81 Bn	273.67 Mn	-

Download Data